Heranba Industries Ltd Share Price – NSE /  BSE

Agro Chemicals, Small Cap

Net Loss of Heranba Industries reported to Rs 57.82 crore in the quarter ended March 2026 as against net loss of Rs 41.49 crore during the previous quarter ended March 2025. Sales declined 4.57% to Rs 319.48 crore in the quarter ended March 2026 as against Rs 334.77 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 76.42 crore in the year ended March 2026 as against net profit of Rs 3.07 crore during the previous year ended March 2025. Sales rose 13.14% to Rs 1594.99 crore in the year ended March 2026 as against Rs 1409.73 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Heranba Industries will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Heranba Industries will hold a meeting of the Board of Directors of the Company on 27 April 2026.

Fentaamine is a next-generation bio stimulant engineered to enhance plant metabolism, improve stress tolerance, and boost crop yield. MycoHil is an advanced biofertilizer designed to improve nutrient absorption, strengthen soil microbiology, and promote sustainable agriculture practices. The products have been developed in collaboration with a leading American multinational company, combining global research expertise with Heranba?s robust manufacturing capabilities.

The company?s foray into crop nutrition aligns with its Vision 2026 growth strategy. It has set a target to achieve total turnover of Rs 2,500 crore in the current fiscal year. Additionally, Heranba plans to expand its presence to over 80 countries and is looking to establish a subsidiary in Dubai to strengthen its footprint in the Middle East and Africa. The company also aims to leverage its seven manufacturing facilities and scale up its contract manufacturing organization (CMO) operations to enhance capacity utilization and build brand equity.

R. K. Shetty, managing director of Heranba Industries, said, ?The crop nutrition segment is witnessing a strong CAGR of over 15% globally and in India. Our entry into this space is a natural strategic progression. We are targeting accelerated growth from this segment over the next three years. By integrating global R & D with our manufacturing strengths, we aim to deliver world-class, sustainable solutions to farmers.?

Heranba Industries is engaged in the manufacture of synthetic pyrethroids and their intermediates. The company has an integrated presence across the agrochemical value chain, spanning technicals to formulations, and focuses on enhancing crop productivity while supporting global food security initiatives.

The company reported consolidated net loss of Rs 23.25 crore in Q3 FY26 compared with net loss of Rs 10.19 crore in Q3 FY25. Net sales declined 11.7% YoY to Rs 301.37 crore in Q3 FY26.